Introduction
Since the report by Macintosh in 1943 about the complications arising from an inadvertent intra-arterial injection of thiopental, the dangers of intra-arterial drug injection have been reported in various papers. 1 Intra-arterial drug injections mostly occur accidentally, mainly as iatrogenic complications during anesthesia procedures. 2 The adverse effects, which were reported to occur in up to 29% of patients, are serious, including necrosis, leading to amputation of the affected extremity, infection, pseudoaneurysm, rhabdomyolysis, and compartment syndrome. 2 However, the etiology of such adverse effects has not been clearly identified and treatment methods have not been established yet. Therefore, prevention of inadvertent intra-arterial drug injection is the most important solution to this problem. Persons who belong to the high-risk group for inadvertent intra-arterial drug injection include obese individuals whose veins are difficult to find, drug abusers who perform self-injection without any anatomical knowledge, and those with vascular variations in the forearms. 3 We had encountered a case of necrosis of the thumb after an intra-arterial injection of diclofenac sodium in an artery that was mistaken for a vein in a patient with arterial variation in the forearm. In this study, we report the dangers of intra-arterial drug injection, and the prevention and treatment of its associated effects, along with a literature review.
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Shon et al Case A 63-year-old male patient (180 cm, 75 kg, retired office worker, Korean) was admitted with the chief complaint of necrosis of the left thumb. He was healthy and a non-smoker with no underlying disease, including vascular disease, diabetes, or hypertension and family history. One week before admission, he visited a private clinic because of a cold, and received an injection of diclofenac sodium (OS-beta, Unimed ® ) 90 mg in the left wrist. He developed numbness and severe pain in the distal part of the wrist immediately upon receiving the injection, as well as hypesthesia in the thumb and index finger after several hours. On the following day, he developed swelling and cyanosis of the thumb and index finger. Necrosis of the distal end of the thumb started developing from the third day after the injection. Subsequent ultrasonography at another hospital indicated reduced blood flow to all fingers of the left hand and no measurable blood flow in the left thumb. Consequently, the patient was prescribed beraprost 40 mg twice a day. Even though he was taking the medication, his symptoms and necrosis worsened, and he visited our hospital after becoming aware of the possibility of needing an amputation. At the time of admission to our hospital, necrosis from the interphalangeal joint to the distal end on the left thumb was observed and an injection mark was visible in the proximal portion of the radial styloid process (Figure 1 ). But there was no abnormality in the patient's laboratory data. Strong pulse was palpable in the proximal portion of the radial styloid process of both wrists, but not where the radial artery is generally located. Variation in the superficial dorsal antebrachial artery was identified on angiographic CT (Figure 2 ). After confirming the boundary of the necrotic area, the proximal phalanx was amputated. Thumb reconstruction was not performed because the patient chose not to undergo the procedure.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Discussion
Since the introduction of thiopental in 1943, other reported drugs for intra-arterial injection have included psychotropic drugs or anesthetics such as promethazine, propofol, diazepam, methohexital, depomedrol, and benzodiazepine.
1 Intraarterial drug injections mostly occur because of iatrogenic complications during anesthesia procedures, as well as in drug abusers who perform self-injection without any anatomical knowledge. 2 However, normal arterial drug injection is used for the treatment of femoral artery pseudoaneurysm, chemotherapy for some tumors and monitoring catheter during anesthesia or in the intensive care unit. Diclofenac sodium, which was injected in the patient in this case, is a nonsteroidal anti-inflammatory drug commonly used in clinical settings, and usually administered through intramuscular or intravenous injection. The known adverse effects of intramuscular injection of diclofenac include rhabdomyolysis and myopathy. 4 Samanta and Samanta 5 and Kumar et al 6 reported cases of amputation due to necrosis of the finger after an intra-arterial injection of diclofenac in a radial artery mistaken for a vein. The rate of amputation of an extremity due to the adverse effects of intra-arterial drug injection is 29%. Among such cases, the rate of amputation resulting from intra-arterial benzodiazepine injection is high (up to 50%). 2 The risk factors of inadvertent intra-arterial drug injection include obesity, which makes the veins difficult to find; self-injection by drug abusers with no anatomical knowledge; and vascular variations in the forearm. Juric et al 7 introduced the subcutaneous vein detection solution using near-infrared spectroscopy. This is the most recent technology to become 
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Inadvertent intra-arterial drug injection available that can be used as a guidance tool to facilitate vein identification. It is especially beneficial for high-risk populations. Among the high-risk populations, variations in the forearm radial artery are the most common cause of inadvertent intra-arterial injection. The most common variation in the forearm radial artery is a high-rising radial artery that forms superficial branches, terminates in the thenar region or binds with the ulnar artery to form a palmar arch that eventually forms superficial palmar branches. 7 Another variation of the radial artery involves the superficial dorsal antebrachial artery that forms an incomplete palmar arch between the thumb and index finger. 8 This crosses the cephalic vein on the superficial portion of the radial styloid process, causing it to be mistaken for an intravenous injection site. Among radial artery variations, superficial dorsal antebrachial artery variation has been reported to have a prevalence of ~1%. As it shows no specific symptoms, it may not be detected unless angiography is performed. Brown et al 9 performed angiography in patients with superficial dorsal antebrachial artery variation and reported that ~13% of the patients had an incomplete form of such variation, in which the superficial palmar arch that supplies blood to the thumb does not anastomose with the ulnar artery. In such cases, when drug is injected in the radial artery or vascular damage occurs, necrosis of the thumb may occur because of the absence of blood supply to the ulnar artery. In our case, we believe that as the superficial dorsal antebrachial artery, which branches in the forearm, passed above the radial styloid process, it was mistaken for the cephalic vein, which is commonly used for intravenous injections.
Symptoms that appear after intra-arterial drug injection include acute pain, numbness, and burning sensation in the peripheral and distal areas from the injection site, as well as neurosensory symptoms such as an abnormal sensation. Pseudoaneurysm, rhabdomyolysis, and compartment syndrome and tissue necrosis may occur within a few days and cause permanent functional damage. 3 Of the total patients, 78% had severe pain, 37% had neurological symptoms, and 17% had terminal necrosis. 2 Although the exact mechanism of such tissue damage has not been identified, vasoconstriction, thrombus formation, crystallization, endothelial inflammatory response, cytotoxicity response, and hyperosmolarity have been reported as possible causes. 3 Therefore, the treatment decision should be based on the mechanism, including the use of an arterial vasodilator, anticoagulant therapy, selective use of thrombolytic agent, use of inflammatory antagonist, and steroid therapy, whereas prophylactic antibiotics should be used to prevent infection. 2, 3 Devulapalli et al 2 reported
an amputation rate of 4% within 14 h of intra-arterial drug injection and an amputation rate of 46% after 14 h. Inadvertent intra-arterial drug injection can cause serious adverse effects such as necrosis and amputation of the ends of the extremities, regardless of the drug; however, the etiology of such adverse effects has not been identified and treatment methods have not been established yet. Therefore, the best option would be to identify the associated risk factors and symptoms, along with the prevention of inadvertent intraarterial drug injection and treatment of its adverse effects upon early detection. In the present case, severe pain and numbness were identified immediately after the injection. Had these signs been used to suspect intra-arterial drug injection and appropriate treatment administered early, the possibility of amputation could have been reduced.
Conclusion
Clinically, it is not easy to prevent inadvertent intra-arterial drug injection. Therefore, early detection of an event and initiation of treatment is a way to reduce the amputation rate of distal extremities. Although the subsequent treatments such as pain control, anticoagulation, rehabilitation, and specific therapy are relatively standardized methods, the correlation with pathophysiology remains unclear.
